MULTI-TYROSINE KINASE INHIBITOR-ASSOCIATED APLASTIC ANEMIA AND A BRIEF LITERATURE REVIEW
Objective: Chronic myeloid leukemia (CML) is a malignancy classified under the group of chronic myeloproliferative neoplasms. It is characterized by uncontrolled leukocytosis, bleeding, thrombosis, recurrent infections, and hepatosplenomegaly. With the introduction of imatinib in 2001, followed by t...
Saved in:
| Main Authors: | Veysel Erol, Zeki Guzel, Mustafa Gokoglu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2024-12-01
|
| Series: | Hematology, Transfusion and Cell Therapy |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2531137924028785 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
TYROSINE KINASE INHIBITORS AND PREGNANCY
by: Elisabetta Abruzzese, et al.
Published: (2014-04-01) -
TYROSINE KINASE INHIBITORS AND INTERFERON
by: Maria Dimou, et al.
Published: (2014-01-01) -
Chloramphenicol-associated aplastic anemia: A review
by: Sanatkumar Bharamu Nyamagoud, et al.
Published: (2025-01-01) -
Cyclin-Dependent Kinase 4/6 Inhibitor (Palbociclib) Induced Aplastic Anemia in a Patient with Metastatic Breast Cancer
by: Stanley Madu Nwabudike, et al.
Published: (2018-01-01) -
Unusual Cutaneous Reaction with Erlotinib: A Brief Report with Current Review of Management of Tyrosine Kinase Inhibitor-associated Cutaneous Toxicity
by: Aashita, et al.
Published: (2025-04-01)